Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Stason Pharmaceuticals, Inc.

Stason Pharmaceuticals, Inc. Recalls

All product recalls associated with Stason Pharmaceuticals, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

303

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 2821–2840 of 4747 recalls

Selegiline HCL Tablets (Stason) – Dissolution Failure (2016)

Stason Pharmaceuticals is recalling Selegiline HCl tablets, USP 5mg 60 count bottle due to an out of specification result for dissolution of stability samples.

Class IIILow

FDAAug 23, 2016NC• Stason Pharmaceuticals, Inc.

Daytrana Patch (Noven) – Delivery System Defect (2016)

Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.

Class IIModerate

FDAAug 22, 2016Nationwide• Noven Pharmaceuticals, Inc.

Daytrana Patch (Noven) – Delivery System Defect (2016)

Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.

1...140 141142143 144...238

Page 142 of 238Next

Class IIModerate

FDAAug 22, 2016Nationwide• Noven Pharmaceuticals, Inc.

Daytrana Patch (Noven) – Defective Delivery System (2016)

Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.

Class IIModerate

FDAAug 22, 2016Nationwide• Noven Pharmaceuticals, Inc.

Lamotrigine Tablets (Unichem) – Incorrect Tablet Imprint (2016)

Tablets/Capsules Imprinted With Wrong ID: incorrect imprint debossed on the tablets.

Class IIILow

FDAAug 19, 2016Nationwide• Unichem Pharmaceuticals Usa Inc

Amoxicillin Suspension (West-Ward) – Missing Label Panel (2016)

Labeling: Label Error on Declared Strength- bottles missing colored coded panel where strength of the product is displayed.

Class IIILow

FDAAug 18, 2016Nationwide• West-Ward Pharmaceuticals Corp.

BuPROPion (Zydus) – Dissolution Failure (2016)

Failed Dissolution Specifications: Product did not meet dissolution specification at an intermediate time point.

Class IIILow

FDAAug 3, 2016Nationwide• Zydus Pharmaceuticals USA Inc

Ground Turmeric (J M Exotic Foods) – Lead Levels (2016)

The firm received a notice from their supplier that a sample of ground turmeric was tested and found to have elevated levels of lead.

Class IHigh

FDAAug 2, 2016AL, GA• J M Exotic Foods Inc

Cranberry Tablets (Reese Pharmaceutical) – Undeclared Calcium (2016)

The finished product label on the Cranberry supplement does not include Calcium. Users of the product may be unaware of the Calcium in the supplement. Additionally the amount per serving as written on the product label is incorrect and should be 500mg, not 900mg.

Class IIILow

FDAAug 2, 2016AL, AZ, CA +16 more• Reese Pharmaceutical Company

Amikacin Sulfate Injection (Teva) – CGMP Deviation (2016)

CGMP Deviations

Class IIModerate

FDAJul 29, 2016Nationwide• Teva Pharmaceuticals USA

Amikacin Sulfate Injection (Teva) – CGMP Deviation (2016)

CGMP Deviations

Class IIModerate

FDAJul 29, 2016Nationwide• Teva Pharmaceuticals USA

Cetylev Effervescent Tablets (Arbor Pharmaceuticals) – Defective Container (2016)

Defective Container: Incomplete seal on blister packaging, leading to tablet swelling and enlarging due to effervescence process beginning as oxygen and moisture enter the blister packaging.

Class IHigh

FDAJul 21, 2016CA, FL, GA +11 more• Arbor Pharmaceuticals Inc.

Venlafaxine HCL ER 150mg (Zydus) – Dissolution Failure (2016)

Failed Dissolution Specifications: out of specification dissolution results in retained samples

Class IIModerate

FDAJul 19, 2016Nationwide• Zydus Pharmaceuticals USA Inc

Venlafaxine HCL ER Capsule (Zydus) – Dissolution Failure (2016)

Failed Dissolution Specifications: out of specification dissolution results in retained samples

Class IIModerate

FDAJul 19, 2016Nationwide• Zydus Pharmaceuticals USA Inc

Trokendi XR Capsules (Supernus) – Superpotent Drug Issue (2016)

Superpotent Drug: Failure of assay specifications in the capsule.

Class IIModerate

FDAJul 12, 2016Nationwide• Supernus Pharmaceuticals, Inc.

Walnut Fudge Brownie (7-Eleven) – Undeclared walnut allergen (2016)

Undeclared Allergen

Bakery Express Mid Atlantic, Inc. is recalling the 7-Eleven, Fresh To Go, Walnut Fudge Brownie products because of an undeclared walnut allergen. An incorrect chocolate cookie label was placed on the retail packets of walnut fudge brownies.

Class IIModerate

FDAJul 6, 2016Nationwide• Bakery Express - Mid Atlantic, Inc.